Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated:  9/17/2015
United States, Texas
mi
from
San Antonio, TX
Study to Evaluate a New Device Designed to Collect Heart Activity and Body Movement Data
Pilot Study to Evaluate a Baseline Prototype Device Designed to Collect ECG (Electrocardiogram) and Accelerometer Data
Status: Enrolling
Updated: 9/17/2015
United States, Texas
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Dothan, AL
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Dothan, AL
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Goodyear, AZ
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Goodyear, AZ
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
mi
from
Orange City, CA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
mi
from
Orange City, CA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Sacramento, CA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Wildomar, CA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Wildomar, CA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Norwich, CT
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Norwich, CT
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Bradenton, FL
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Bradenton, FL
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Orange City, FL
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Orange City, FL
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Tampa, FL
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Atlanta, GA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Waldorf, MD
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Waldorf, MD
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Bloomfield Hills, MI
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Bloomfield Hills, MI
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
mi
from
Mt Arlington, NJ
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
mi
from
Mt Arlington, NJ
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Summit, NJ
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Summit, NJ
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Manhasset, NY
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Manhasset, NY
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Rochester, NY
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Avon Lake, OH
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Avon Lake, OH
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Cleveland, OH
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Houston, TX
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
San Antonio, TX
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Orem, UT
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Norfolk, VA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Petersburg, VA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Petersburg, VA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
Clinical Research Facility
mi
from
Bellevue, WA
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
Clinical Research Facility
mi
from
Bellevue, WA
Click here to add this to my saved trials
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated:  9/17/2015
mi
from
Toronto,
Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder
Status: Enrolling
Updated: 9/17/2015
mi
from
Toronto,
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Togus VA Medical Center
mi
from
Augusta, ME
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Togus VA Medical Center
mi
from
Augusta, ME
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Durham VA Medical Center
mi
from
Durham, NC
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Cincinnati VA Medical Center
mi
from
Cincinnati, OH
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Cincinnati VA Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
VA Puget Sound Health System
mi
from
Seattle, WA
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
VA Puget Sound Health System
mi
from
Seattle, WA
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
VA San Diego Healthcare System
mi
from
La Jolla, CA
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
VA San Diego Healthcare System
mi
from
La Jolla, CA
Click here to add this to my saved trials
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated:  9/18/2015
Walter Reed National Military Medical Center
mi
from
Washington,
Acceptance and Commitment Therapy (ACT) for OEF/OIF Veterans
Initial Randomized Controlled Trial of Acceptance and Commitment Therapy (ACT) for Distress and Impairment in OEF/OIF Veterans
Status: Enrolling
Updated: 9/18/2015
Walter Reed National Military Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  9/18/2015
UCLA Semel Institute
mi
from
Los Angeles, CA
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
Neurophysiological Attention Test (NAT) for Objective Assessment of Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 9/18/2015
UCLA Semel Institute
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials
Diagnostic Utility of ADHD by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials
Status: Enrolling
Updated:  9/21/2015
Massachusetts General Hospital
mi
from
Boston, MA
Diagnostic Utility of Attention Deficit Hyperactivity Disorder (ADHD) by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials
Diagnostic Utility of ADHD by Brain Activity Flow Patterns Analysis Using Evoked Response Potentials
Status: Enrolling
Updated: 9/21/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
The Assessment of Movement Disorders Utilizing Live Two-Way Video
The Assessment of Movement Disorders Utilizing Live Two-Way Video
Status: Enrolling
Updated:  9/21/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
The Assessment of Movement Disorders Utilizing Live Two-Way Video
The Assessment of Movement Disorders Utilizing Live Two-Way Video
Status: Enrolling
Updated: 9/21/2015
The Zucker Hillside Hospital
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia With Option of Prism Adaptation Treatment (PAT) Protocol
Status: Enrolling
Updated:  9/21/2015
Adler Aphasia Center
mi
from
Maywood, NJ
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia
An Assessment of the Prevalence of Spatial Neglect in Stroke Survivors With Aphasia With Option of Prism Adaptation Treatment (PAT) Protocol
Status: Enrolling
Updated: 9/21/2015
Adler Aphasia Center
mi
from
Maywood, NJ
Click here to add this to my saved trials
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
Phase IIb Study Comparing Tenecteplase to Alteplase in Acute Ischemic Stroke Within 3 to 4.5 Hours From Symptom Onset
Status: Enrolling
Updated:  9/22/2015
The Ohio State University College of Medicine
mi
from
Columbus, OH
Tenecteplase Versus Alteplase in Ischemic Stroke Management (TALISMAN)
Phase IIb Study Comparing Tenecteplase to Alteplase in Acute Ischemic Stroke Within 3 to 4.5 Hours From Symptom Onset
Status: Enrolling
Updated: 9/22/2015
The Ohio State University College of Medicine
mi
from
Columbus, OH
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
University of Florida
mi
from
Gainesville, FL
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Carolinas Medical Center, Neurosciences and Spine Institute
mi
from
Charlotte, NC
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Carolinas Medical Center, Neurosciences and Spine Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Monroe Carell Jr. Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Methodist Neurological Institute
mi
from
Houston, TX
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Methodist Neurological Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
University of California, Davis Medical Center
mi
from
Sacramento, CA
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
University of California, Davis Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated:  9/23/2015
Dr. Günther Bernert, Prim. Univ. Doz.
mi
from
Wien,
Phase III Study of Idebenone in Duchenne Muscular Dystrophy (DMD)
A Phase III Double-Blind, Randomised, Placebo-Controlled Study of the Efficacy, Safety and Tolerability of Idebenone in 10-18 Year Old Patients With Duchenne Muscular Dystrophy
Status: Enrolling
Updated: 9/23/2015
Dr. Günther Bernert, Prim. Univ. Doz.
mi
from
Wien,
Click here to add this to my saved trials
Dysport® Adult Upper Limb Spasticity
A Phase III, Multicentre, Prospective, Double Blind, Randomised, Placebo Controlled Study, Assessing the Efficacy and Safety of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated:  9/23/2015
Associated Neurologist of Southern CT, PT
mi
from
Fairfield, CT
Dysport® Adult Upper Limb Spasticity
A Phase III, Multicentre, Prospective, Double Blind, Randomised, Placebo Controlled Study, Assessing the Efficacy and Safety of Dysport® Intramuscular Injections Used for the Treatment of Upper Limb Spasticity in Adult Subjects With Spastic Hemiparesis Due to Stroke or Traumatic Brain Injury
Status: Enrolling
Updated: 9/23/2015
Associated Neurologist of Southern CT, PT
mi
from
Fairfield, CT
Click here to add this to my saved trials